Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameSinohealth Tech
Stock Code02361
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們主要提供健康洞察解決方案,以解決醫療產品製造商客戶的銷售及營銷需求。該等解決方案主要基於我們的零售數據,而零售數據佔我們健康大數據的大部分。我們在醫療產品及渠道分部處於領先地位。
Listing Date2022-07-12
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國廣東省廣州市南沙區黃閣鎮望江二街5號1111房
Business Address (Hong Kong)香港灣仔皇后大道東248號大新金融中心40樓
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websiteir.sinohealth.cn
Share Registrar宝德隆
Registrar Contact(852)2153 1688
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 5.36 / shares
Offer Price RangeFinal offer price only, no range
Lot Size500 shares
Entry ThresholdHK$ 2,680
Par ValueTo be extracted
Offer Period2022-06-28 to 2022-07-05
Global Offering Shares75,000,000 shares
HK Public Offer Shares (Initial)7,500,000 shares (10.0%)
Public Offer Lots (Initial)15,000lots (Pool A7,500lots,Pool B7,500lots)
International Placing Shares (Initial)67,500,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO450,000,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share32.5%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 402,000,000

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 500 HK$ 2,680
2 lots 1,000 HK$ 5,360
3 lots 1,500 HK$ 8,040
4 lots 2,000 HK$ 10,720
5 lots 2,500 HK$ 13,400
6 lots 3,000 HK$ 16,080
7 lots 3,500 HK$ 18,760
8 lots 4,000 HK$ 21,440
9 lots 4,500 HK$ 24,120
10 lots 5,000 HK$ 26,800
15 lots 7,500 HK$ 40,200
20 lots 10,000 HK$ 53,600
25 lots 12,500 HK$ 67,000
30 lots 15,000 HK$ 80,400
40 lots 20,000 HK$ 107,200
50 lots 25,000 HK$ 134,000
75 lots 37,500 HK$ 201,000
100 lots 50,000 HK$ 268,000
150 lots 75,000 HK$ 402,000
200 lots 100,000 HK$ 536,000
250 lots 125,000 HK$ 670,000
300 lots 150,000 HK$ 804,000
400 lots 200,000 HK$ 1,072,000
1,000 lots 500,000 HK$ 2,680,000
1,500 lots 750,000 HK$ 4,020,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 1.73B
Est. Threshold HK$ 9.71B
Analysis Result HK market cap below threshold, need +461%

Valuation & Financials

Market Cap (at Offer Price)HK$ 2,412,000,000
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約人民幣72.0百萬元
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 201920202021
Revenue 177,750202,073324,166
Cost of sales -71,654-71,867-131,527
Gross profit 106,096130,206192,639
Other income and gains, net 15,66219,02629,537
Selling and distribution expenses -10,691-14,833-24,786
Administrative expenses -12,780-16,585-44,163
Net finance costs -576-1,222-532
Share of associates and JVs 00-416
Profit before tax 67,11576,07295,529
Income tax expense -12,736-10,743-23,551
Profit for the year 54,37965,32971,978
Profit attributable to owners 56,08967,92678,813
Balance Sheet
Item 201920202021
Cash and cash equivalents 220,635115,77833,955
Trade and bills receivables 19,53628,71281,866
Inventories 599573680
Total current assets 423,462507,161500,414
Total assets 440,851542,207517,023
Total current liabilities 37,59655,28296,138
Total liabilities 44,92577,582101,112
Total equity 395,926464,625415,911
Equity attributable to owners 394,739462,665416,858
Cash Flow Statement
Item 201920202021
Net cash from operating activities 57,84461,59860,020
Net cash from investing activities -180,558-166,559-9,469
Net cash from financing activities -4,053103-132,410
Net increase in cash -126,767-104,858-81,859
Depreciation of PP&E 1,6011,9342,083
Depreciation of right-of-use assets 3,8275,5194,849
Amortisation of intangible assets 414430420
Purchase of PP&E -4,157-933-1,878
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 5.36
First Day OpenHK$ 4.74
First Day Change-8.21%
First Day Volume21540500.0
First Day Turnover111142000.0
Use of Proceeds
1、約50.8%,或170.4百萬港元將主要用于升級及提升我們的SaaS產品(專注于智慧決策云、智慧零售云及智慧醫療云)以及其營銷及推廣; 2、約49.2%,即165.0百萬港元將主要用于對我們的技術及數據倉庫進行進一步研發。

Underwriting Syndicate

Sole Sponsor (1)
BNP PARIBAS SECURITIES (ASIA) LIMITED CE AAF669
Overall Coordinators (3)
BNP PARIBAS SECURITIES (ASIA) LIMITED CE AAF669 建银国际金融有限公司 CE AJO225 ORIENT SECURITIES (HONG KONG) LIMITED CE AVD362
Joint Bookrunners (8)
BNP PARIBAS SECURITIES (ASIA) LIMITED CE AAF669 建银国际金融有限公司 CE AJO225 ORIENT SECURITIES (HONG KONG) LIMITED CE AVD362 海通国际证券有限公司 CE AAF806 UOB KAY HIAN (HONG KONG) LIMITED CE AAW261 国泰君安证券(香港)有限公司 CE ABY236 Eddid Securities and Futures Limited CE BHT550 ZHONGTAI INTERNATIONAL SECURITIES LIMITED CE BAA855
Joint Lead Managers (12)
BNP PARIBAS SECURITIES (ASIA) LIMITED CE AAF669 建银国际金融有限公司 CE AJO225 ORIENT SECURITIES (HONG KONG) LIMITED CE AVD362 海通国际证券有限公司 CE AAF806 UOB KAY HIAN (HONG KONG) LIMITED CE AAW261 国泰君安证券(香港)有限公司 CE ABY236 Eddid Securities and Futures Limited CE BHT550 ZHONGTAI INTERNATIONAL SECURITIES LIMITED CE BAA855 富途证券国际(香港)有限公司 CE AZT137 AUSTRAX SECURITIES LIMITED CE BHV052 Fosun International Securities Limited CE AAF432 Livermore Holdings Limited CE BJN764

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Lun’s Family Holdings Limited 15,535,960 HKD — 3.86% — 6 months 2023-01-12
2 百洋健康产业国际商贸有限公司 29,699,760 HKD — 7.39% — 6 months 2023-01-12
3 广东康石壹号私募股权投资合伙企业(有限合伙) 38,661,680 HKD — 9.62% — 6 months 2023-01-12
4 郑靖杰 46,865,160 HKD — 11.66% — 6 months 2023-01-12

Directors & Management

PositionChinese nameEnglish Name
Chairman吳鬱抒—
Company Secretary易旭暉—
No director data available.

Major Shareholders

Major Shareholders & Holdings吳鬱抒及王莉芳通過盈連BVI、WLF BVI、Rikan LLP合計持有約59.775%;李捍雄及吳美容通過Montesy Capital BVI持有約15.225%;俞熔通過上海天億BVI及中衛騰雲BVI持有約7.9412%
About this page

This page shows Sinohealth Tech (02361) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect